Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial
Vaucher P, Druais PL, Waldvogel S, Favrat B
Published in Canadian Medical Association Journal
Methodology
Randomized, double-blind, placebo-controlled trial of 80 mg/day oral iron for 12 weeks in non-anaemic menstruating women with unexplained fatigue and ferritin below 50 ug/L.
Key Findings
Iron reduced fatigue by about 48% from baseline versus 29% with placebo, a statistically significant difference, while haemoglobin was unchanged.
Conclusions
Oral iron improves unexplained fatigue in non-anaemic women with low ferritin.
Limitations
Subjective primary outcome; single-country primary-care sample; 12-week duration.
Supplements Studied
Iron reduced fatigue by about 48% from baseline versus 29% with placebo in non-anaemic women with low ferritin.
Outcomes Measured
Iron significantly reduced fatigue compared with placebo in women with low ferritin.
Iron supplementation reduced fatigue in nonanemic menstruating women with low ferritin.
The mean score on the Current and Past Psychological Scale for fatigue decreased by 47.7% in the iron group and by 28.8% in the placebo group (difference -18.9%, 95% CI -34.5 to -3.2; p=0.02)
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Swiss academic funding with study drug from manufacturer
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.